Tamara van Donge

Kidney injury biomarkers in pediatrics 175 9 Sample size Sample Biomarkers Total: 368 3-5 years: 94 5-10 years: 89 10-15 years: 93 15-18 years: 92 Urine ADP, CP, HPX, KIM-1, MALB, MCP-1, NGAL Total: 368 3-5 years: 94 5-10 years: 89 10-15 years: 93 15-18 years: 92 Urine IL-18, L-FABP, KIM-1, NGAL Total: 81 <26 weeks: 13 26-27 weeks: 20 28-29 weeks: 30 >30 weeks: 18 Urine ALB, B2M, CYSC, EGF, NGAL, OPN, UMOD, CTN, KIM-1, OAN, TFF3, VEGF, CBN, GST, UCR Total: 95 <1 weeks of age: 11 2 weeks < 1 month: 6 2 months: 11 3 months: 21 4-6 months: 26 7-12 months: 20 Serum BTP, CYSC Total: 106 1 month (boys: 8, girls: 7) 2–3 months (boys: 30, girls: 12) 4–6 months (boys: 20, girls: 6) 7–12 months (boys: 13, girls: 10) Urine KIM-1, NGAL Total: 1131 (b oys: 504, girls: 627) 3-8 months: 39 9 months – 1 year: 98 2-3 years: 158 4-9 years: 448 10-14 years: 294 15-16 years: 94 Serum B2M Total: 333 Neonates (1 – 4 days): 25 Children (0.63 – 248 months): 308 Urine NGAL